Journal of the National Cancer Institute, ‎0027-8874

Journal

Publications

  1. 2021
  2. Published

    The effect of metformin vs placebo on sex hormones in Canadian cancer trials group MA.32

    Daniel Rea & 5 others, , , , & , Feb 2021, In: Journal of the National Cancer Institute. 113, 2, p. 192-198 7 p.

    Research output: Contribution to journalArticlepeer-review

  3. 2019
  4. Published

    Systematic evaluation of Patient-Reported Outcome protocol content and reporting in cancer trials

    Derek Kyte, Ameeta Retzer, Khaled Ahmed, Tom Keeley, , , , , , , , , , , , , , Grace Turner & Melanie Calvert, Nov 2019, In: Journal of the National Cancer Institute. 111, 11, p. 1170-1178 9 p.

    Research output: Contribution to journalArticlepeer-review

  5. 2018
  6. Published
  7. Published

    Risk of soft-tissue sarcoma among 69 460 five-year survivors of childhood cancer in Europe

    Michael Hawkins & 21 others, , , , , , , , , , , , , , , , , , , , Raoul Reulen & , Jun 2018, In: Journal of the National Cancer Institute. 110, 6, p. 649–660

    Research output: Contribution to journalArticlepeer-review

  8. Published

    Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe

    Raoul Reulen & 20 others, , , , , , , , , , , , , , , , , , , & Michael Hawkins, Feb 2018, In: Journal of the National Cancer Institute. 110, 2

    Research output: Contribution to journalArticlepeer-review

  9. Published
  10. 2017
  11. Published
  12. 2016
  13. Published
  14. Published
  15. 2015
  16. Published
  17. 2012
  18. Published

    Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis

    Anthony Kong, , & , 7 Nov 2012, In: Journal of the National Cancer Institute. 104, 21, p. 1625-34 10 p.

    Research output: Contribution to journalArticlepeer-review

  19. 2010
  20. Published
  21. 2009
  22. Published

    Re: Selenium and Vitamin E: Interesting Biology and Dashed Hope

    Maurice Zeegers, 7 Oct 2009, In: Journal of the National Cancer Institute. 101, 19, p. 1363-1364 2 p.

    Research output: Contribution to journalArticle

  23. Published
  24. 2008
  25. Published

    Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial

    Emilio Porfiri & , 15 Oct 2008, In: Journal of the National Cancer Institute. 100, 20, p. 1454-63 10 p.

    Research output: Contribution to journalArticle

  26. Published

    Speeding up the evaluation of new agents in cancer

    Nicholas James, , , & , 1 Sep 2008, In: Journal of the National Cancer Institute. 100, 17, p. 1204-1214 11 p.

    Research output: Contribution to journalEditorial

  27. Published
  28. 2007
  29. Published
  30. 2006
  31. Published

    Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

    Jayne Wilson, , , , Josie Sandercock, , , , , , , Christopher Hyde & , 17 May 2006, In: Journal of the National Cancer Institute. 98, 10, p. 708-714 7 p.

    Research output: Contribution to journalArticlepeer-review

  32. Published

    PMS2 mutations in childhood cancer

    Eamonn Maher, , , , , , & , 1 Jan 2006, In: Journal of the National Cancer Institute. 98, 5, p. 358-361 4 p.

    Research output: Contribution to journalArticle

  33. 2005
  34. Published
  35. Published
  36. Published
  37. Published
  38. 2004
  39. Published
  40. 2002
  41. Published
  42. Published
  43. 2001
  44. Published

    Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression

    Farida Latif, , , , , , & , 1 May 2001, In: Journal of the National Cancer Institute. 93, 9, p. 691-699 9 p.

    Research output: Contribution to journalArticle